AquaBounty Technologies (NASDAQ:AQB) Issues Earnings Results, Hits Expectations

AquaBounty Technologies (NASDAQ:AQB) announced its quarterly earnings data on Tuesday. The company reported ($0.88) EPS for the quarter, hitting the consensus estimate of ($0.88), RTT News reports. The business had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. During the same quarter in the previous year, the firm posted ($1.60) earnings per share.

AquaBounty Technologies Stock Performance

Shares of AQB stock opened at $1.10 on Thursday. The firm’s 50 day moving average is $1.13 and its 200 day moving average is $1.47. The stock has a market capitalization of $4.25 million, a P/E ratio of -0.06 and a beta of 1.15. AquaBounty Technologies has a 12 month low of $0.81 and a 12 month high of $4.03. The company has a current ratio of 1.96, a quick ratio of 1.96 and a debt-to-equity ratio of 0.05.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.